Goldman Sachs U.S. Equity Insights Fund ABT Holdings History
Goldman Sachs U.S. Equity Insights Fund's Abbott Laboratories Holding Summary
As of 2025-04-30, GOLDMAN SACHS TRUST held 101,321.00 shares of Abbott Laboratories(ABT), totaling $13.25 Mil. This investment constitutes 1.33% of their stock portfolio, and GOLDMAN SACHS TRUST now holds 0.01% of the outstanding Abbott Laboratories(ABT) stock.
The initial trade took place in 2020Q2. And since then Goldman Sachs U.S. Equity Insights Fund has made 5 purchases of ABT, at an average price of $116.83, for a total of 192,078.00 shares. In addition, there have been 2 sales at an average price of $100.38 for 90,757.00 shares. Based on historical transaction data and ABT's current price of $126.14, Goldman Sachs U.S. Equity Insights Fund's estimated gain on his ABT holdings is $-550,956.68, reflecting a -2.46% gain to date.
Goldman Sachs U.S. Equity Insights Fund ABT ($126.14) Holding Chart
Goldman Sachs U.S. Equity Insights Fund ABT ($126.14) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
